Pimagedine, also known as aminoguanidine, is a hydrazine derivative classified as an oral antidiabetic agent primarily investigated for the treatment of diabetic nephropathy through the inhibition of advanced… Read more
Pimagedine, also known as aminoguanidine, is a hydrazine derivative classified as an oral antidiabetic agent primarily investigated for the treatment of diabetic nephropathy through the inhibition of advanced glycation end-products. This category features high-quality reference standards of Pimagedine API, alongside its pharmacopeial and non-pharmacopeial impurities, such as Aminoguanidine hydrochloride, and stable isotope labelled compounds. These specialized products are essential tools for pharmaceutical laboratories engaged in impurity profiling, method validation, and rigorous quality control testing. By utilizing these precisely characterized materials, researchers can ensure accurate quantification and identification of degradation products or synthesis-related impurities throughout the drug development lifecycle. These analytical standards support compliance with regulatory requirements, facilitating reliable data generation during stability studies and routine testing protocols for this therapeutic compound.